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Evidence-based parenting interventions play a crucial role in the sustained reduction of adolescent behavioral
health concerns. Guiding Good Choices (GGC) is a 5-session universal anticipatory guidance curriculum for
parents of early adolescents that has been shown to reduce substance use, depression symptoms, and delinquent
behavior. Although prior research has demonstrated the effectiveness of evidence-based parenting interventions
at achieving sustained reductions in adolescent behavioral health concerns, public health impact has been
limited by low rates of uptake in community and agency settings. Pediatric primary care is an ideal setting for
implementing and scaling parent-focused prevention programs as these settings have a broad reach, and pre
vention programs implemented within them have the potential to achieve population-level impact. The current
investigation, Guiding Good Choices for Health (GGC4H), tests the feasibility and effectiveness of implementing
GGC in 3 geographically and socioeconomically diverse large integrated healthcare systems. This pragmatic,
cluster randomized clinical trial will compare GGC parenting intervention to usual pediatric primary care
practice, and will include approximately 3750 adolescents; n = 1875 GGC intervention and n = 1875 usual care.
The study team hypothesizes that adolescents whose parents are randomized into the GGC intervention arm will
show reductions in substance use initiation, the study's primary outcomes, and other secondary (e.g., depression
symptoms, substance use prevalence) and exploratory outcomes (e.g., health services utilization, anxiety
symptoms). The investigative team anticipates that the implementation of GGC within pediatric primary care
clinics will successfully fill an unmet need for effective preventive parenting interventions.
Trial registration: Clinicaltrials.gov NCT04040153

* Corresponding author.
E-mail addresses: hscheuer@uw.edu (H. Scheuer), mrk63@uw.edu (M.R. Kuklinski), stacy.a.sterling@kp.org (S.A. Sterling), catalano@uw.edu (R.F. Catalano),
Arne.Beck@kp.org (A. Beck), jbracis1@hfhs.org (J. Braciszewski), Jennifer.M.Boggs@kp.org (J. Boggs), jdh@uw.edu (J.D. Hawkins), aloree1@hfhs.org
(A.M. Loree), constance.weisner@kp.org (C. Weisner), szcarey@uw.edu (S. Carey), felsiss1@hfhs.org (F. Elsiss), Erica.F.Morse@kp.org (E. Morse), Rahel.X.
Negusse@kp.org (R. Negusse), Andrew.R.Jessen@kp.org (A. Jessen), Andrea.H.Kline-Simon@kp.org (A. Kline-Simon), Sabrina.Oesterle@asu.edu (S. Oesterle),
Charles.Quesenberry@kp.org (C. Quesenberry), Oleg.Sofrygin@kp.org (O. Sofrygin), tyoon1@hfhs.org (T. Yoon).
https://doi.org/10.1016/j.cct.2021.106621
Received 9 July 2021; Received in revised form 1 November 2021; Accepted 9 November 2021
Available online 14 November 2021
1551-7144/© 2021 Elsevier Inc. All rights reserved.

Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by
Elsevier on December 16, 2021. For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.

H. Scheuer et al.

Contemporary Clinical Trials 112 (2022) 106621

1. Introduction

series of pragmatic clinical trials across the United States addressing a
range of public health concerns [29]. The overarching mission of the
Collaboratory is to “strengthen the national capacity to implement costeffective large-scale research studies that engage healthcare delivery
organizations as research partners” [30]. Trials in the Collaboratory are
conducted within real-world healthcare settings and aim to answer
questions of crucial importance to patients, care providers, and re
searchers. A major goal is for findings from Collaboratory trials to affect
clinical practice as quickly as possible, reducing the typically long lag
from “bench to bedside” [31].
GGC4H is the only Collaboratory study targeting youth, and one of
the few focused on prevention. It aligns well with Collaboratory goals in
that most of the team members are healthcare system-embedded re
searchers and have a history of engagement with system stakeholders.
The core team includes three pediatrician partners and regularly en
gages clinics and department heads. The pediatrician role within the
investigation is also pragmatic, designed to be of minimal burden, and
fit within typical clinic workflows. Importantly, GGC is a populationbased universal intervention that is appealing to pediatricians because
they can recommend it to all families of adolescents without the po
tential stigma of referring families to targeted interventions based on
identifying individual risks. Finally, University of Washington Multiple
Principle Investigators (MPI's) included one of the developers of the GGC
curriculum prior to his retirement to aid curriculum adaptation to pri
mary care delivery, and a group-randomized trial expert and health
economist to aid in assessing the impact and cost effectiveness of GGC in
the primary care setting.

Adolescence is a developmental period characterized by significant
physical and psychosocial changes, and often marks the onset of be
haviors and symptomatology that can have lifelong impacts, including
the initiation of substance use, antisocial behavior, and depression [1,2].
Fifty percent of adolescents will use some form of illicit drugs, and 52%
will use alcohol before the end of high school [3,4]; 20% - 25% will meet
criteria for depression [5,6], and some will engage in delinquency and
violence [7,8]. Widespread prevention efforts to reduce the onset of
these health-risking behaviors in diverse populations could improve
adolescent health and wellbeing.
Guiding Good Choices (GGC) is a universal, anticipatory guidance
curriculum for parents of early adolescents, with demonstrated impact
on adolescent health outcomes from two randomized trials, including
one longitudinal investigation [9–15]. Delivered to parents in groups in
five 2-h sessions, GGC provides knowledge, tools, and skills that
strengthen family bonds, promote adolescent health and wellbeing, and
reduce risks for behavioral health problems. Because GGC targets risk
and protective factors that are common predictors of adolescent
behavioral health problems, it is expected to improve multiple out
comes. In prior community trials, GGC prevented adolescent alcohol,
tobacco, and marijuana use, depressive symptoms, and delinquent
behavior, including reductions in alcohol and marijuana use initiation
by 41%, the progression to more serious substance misuse by 54%, and
symptoms of depression by 28%, 4 to 6 years after families were exposed
to GGC in middle school [9,10,16,17]. Furthermore, GGC strengthened
parenting practices and parent-adolescent relationship quality
[12,18–20], two components that are broadly protective for adolescent
health [21,22].
The American Academy of Pediatrics' Bright Futures guidelines
recommend that pediatricians offer developmentally tailored anticipa
tory guidance to all parents to support children's healthy development
[23,24]. Although pediatricians are a trusted source of information
about children's wellbeing, they often lack the time, resources, and selfefficacy to provide tailored guidance to parents of adolescents.
Furthermore, although pediatric primary care is a favorable and
appropriate setting for prevention programs to support parents and
improve adolescent health [25], effective parenting programs that could
provide this guidance are rarely offered through primary care. The
current project, Guiding Good Choices for Health (GGC4H), tests the
feasibility and effectiveness of implementing GGC with parents of 12- to
13-year-old adolescents in three large, integrated healthcare systems
serving geographically and socioeconomically diverse families. The
study uses the Reach, Effectiveness, Adoption, Implementation, and
Maintenance (RE-AIM) framework [26,27] to evaluate implementation
outcomes, effectiveness, costs (now part of the RE-AIM framework), and
cost effectiveness [28], including hypothesized reductions in the study's
primary outcome of substance use initiation, secondary outcomes of
substance use prevalence and frequency, antisocial behavior, and
depression symptoms, and exploratory outcomes including substance
use and mental health disorders, and health services utilization. The
study is assessing costs in relation to value gained. The investigative
team's partnerships with pediatricians and healthcare leaders ensures
that the approach fits pediatric care workflows so that, if effective, it will
be ready and appropriate for broad dissemination to pediatric primary
care settings. Overall, the study fills an essential service gap in pediatric
primary care and has the capacity to achieve population-level impact on
adolescent health.

2.2. Design
The current investigation employs a cluster-randomized design
(Fig. 1) to test GGC effectiveness when implemented at scale within
pediatric primary care practices across three large, geographically
diverse, integrated healthcare systems: Kaiser Permanente Northern
California (KPNC), Henry Ford Health System (HFHS) in Detroit, MI, and
Kaiser Permanente Colorado (KPCO). The memberships of these systems
have different sociodemographic profiles, and the systems themselves
have distinct organizational, health plan coverage, and service delivery
structures, offering the chance to evaluate GGC effectiveness across
diverse systems and members.
Randomization is at the pediatrician level, with covariate constraint
on three pediatrician panel characteristics that could affect adolescent
outcomes or lead to unacceptable levels of imbalance across interven
tion and control arms: panel size, pediatrician gender, and a panel-level
indicator of socioeconomic status (percentage of families on Medicaid)
as a proxy for baseline levels of risk. Constraints ensure balance between
arms after randomization, increasing statistical power and precision.
The cluster-randomized design allows for ease of implementation
around the pediatrician recommendation of GGC, and unlike randomi
zation at the clinic level, cluster-randomization provides sufficient sta
tistical power given the study's budgetary constraints.
After stratifying on healthcare system and clinic and applying con
straints, 75 pediatricians (KPNC n = 21, KPCO n = 29, HFHS n = 25),
were randomized to either the intervention (GGC) or control arm
(intervention arm n = 38, control arm n = 37). Importantly, pilot clinic
data reviewed by the investigative team revealed that 85% of adoles
cents have a well-child visit with the provider with whom they are
empaneled, suggesting limited crossover among providers. Additionally,
research staff only enroll families in GGC who are empaneled with pe
diatricians randomized to the intervention condition. Based on other
intervention studies carried out by various GGC4H partners [32–37], the
study team estimates a recruitment rate of 50% of eligible adolescents
(described in 2.3. Inclusion Criteria), for a total sample of approximately
3750 adolescents, 1875 in each study arm.
Using the Reach, Effectiveness, Adoption, Implementation, and
Maintenance (RE-AIM) framework [27], this investigation evaluates

2. Materials & methods
2.1. NIH health care systems research collaboratory
This pragmatic investigation is part of the NIH Health Care Systems
(HCS) Research Collaboratory (“Collaboratory”), which supports a
2
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Fig. 1. GGC4H study design.
Note. R = Randomization. Pediatricians were stratified on healthcare system and clinic prior to randomization, which included covariate constraint on pediatrician
panel size, pediatrician gender, and a pediatrician panel-level indicator of socioeconomic status (percentage of families insured through Medicaid) as a proxy for
baseline levels of risk.

implementation and effectiveness of the GGC intervention across three
large integrated healthcare systems. The RE-AIM framework allows the
investigative team to measure GGC impacts on both individual and
system levels, and ultimately aims to assess whether the intervention has
the potential to achieve public health impact in real-world healthcare
settings [27,38]. The investigative team hypothesizes that at the study
endpoint, 24 months after baseline, adolescents in the GGC intervention
will show reductions in the primary outcome of substance use initiation,
secondary outcomes of substance use prevalence and frequency,
depressive symptoms, and antisocial behavior, and exploratory out
comes including health services utilization and substance use and
mental health disorders. Study hypotheses will be evaluated utilizing the
RE-AIM framework, allowing the investigative team to assess imple
mentation and effectiveness outcomes as well as implementation and
dissemination potential. The Institutional Review Board (IRB) of Kaiser
Permanente Colorado serves as the primary IRB of record for all sites and
has approved all study procedures.

HIPAA-compliant technology. GGC experts and developers at the Uni
versity of Washington developed a virtual delivery format that retains
all core intervention components, including the large and small group
discussions, modeling of skills, practice exercises that engage parents,
and the opportunity for parents to connect with each other at a time
when social distancing has limited such opportunities. These changes
did not affect the overall study design and were approved by both the
sponsor and the IRB of record.
2.3. Inclusion criteria
2.3.1. Adolescent inclusion criteria
Adolescents are eligible for the study if they are members of one of
the three participating healthcare systems, are served by a participating
pediatric primary care clinic at the time of the baseline survey, and
would be 12 to 13 years old (date of birth 6/1/2007–5/31/2009) during
the study's intervention period. They remain in the study even if they are
no longer a health system member at the time of their follow-up surveys.

2.2.1. COVID-19 implications
Prior to COVID-19, the study timeline involved recruiting half of the
sample in year 2 (“cohort 1”) and half in year 3 (“cohort 2”) and offering
the GGC intervention to cohort 1 parents in year 2 and cohort 2 parents
in year 3. The COVID-19 pandemic began prior to the implementation of
GGC with cohort 1, ultimately delaying GGC implementation with
cohort 1 and recruitment and GGC implementation with cohort 2 by a
year. As a result, a second baseline assessment and implementation of
GGC with cohort 1 was shifted to year 3, and recruitment and imple
mentation of GGC with cohort 2 was shifted to year 4. Recruitment to the
study is ongoing. Both cohorts complete follow-up surveys at 12 and 24
months post baseline (Fig. 1).
The COVID-19 pandemic also led to rapid evolution in healthcare
delivery models, including telehealth delivery of services previously
offered in person. With restrictions on in-person group-based behavioral
interventions into the foreseeable future, the study team shifted imple
mentation delivery to virtual live (synchronous) GGC groups using

2.3.2. Pediatrician inclusion criteria
Pediatricians are included in the trial and randomized if they prac
tice at a participating clinic in year 2 of the study, and do not opt out
after reviewing the Pediatrician Information Form, or after an initial
presentation by the study team describing the study and their role.
A total of 10 participating clinics (KPNC n = 1, KPCO n = 5, HFHS n
= 4) were selected such that collectively they served a sociodemo
graphically diverse patient population. None of the clinics or pediatri
cians approached to participate opted out. The final sample includes 75
pediatricians (intervention arm n = 38, control arm n = 37). Pediatrician
panel sizes averaged 102.1 study-eligible adolescents (SD = 49.1, range:
12 to 299).
2.4. Exclusion criteria
Adolescents and parents are excluded if they have an intellectual,
3
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developmental, or cognitive impairment that would prevent them from
understanding the purpose of the study, study measures, or the GGC
curriculum, or if they reside outside of the United States. For adoles
cents, exclusions are operationalized by specific ICD-9 or ICD-10 diag
nostic codes documented in the electronic health record (EHR; e.g., ICD10 F70-79 Intellectual disabilities, ICD-10 F84 Pervasive developmental
disorders). For parents, impairment is identified by study team members
at the time of recruitment into the study. Additionally, parents whose
primary language is not English, as documented in the EHR or identified
at study recruitment, are not included. EHR data suggests that exclu
sions for non-English speakers are small (approximately 7%). Non-study
parents receiving care from an intervention arm pediatrician may also
be excluded from the intervention at the discretion of pediatricians or
GGC enrollment callers for impairment reasons or because English is not
their primary language.

2.6.2. Intervention: guiding good choices
GGC has been successfully implemented with culturally and ethni
cally diverse families throughout the United States [16]. GGC's efficacy
was established as an in-person group-based intervention. An online,
self-guided curriculum was developed for this trial as an alternative to
the group modality to increase access to the intervention among those
who experience barriers to in-person groups or prefer self-directed
interventions.
2.6.3. Guiding good choices group intervention
GGC is a 5-session program for parents and their adolescents ages
9–14 (Grades 5–8). When delivered virtually, an introductory session is
added to the curriculum prior to Session 1 to encourage virtual
engagement and participation, orient families to the virtual platform,
and provide technology support. GGC's overall goal is to promote
adolescent wellbeing and healthy development through sustained pre
ventive effects on adolescent health-risk behaviors. It also aims to
strengthen protective factors that operate within the family (e.g.,
bonding, healthy communication) and peer contexts. GGC is theoreti
cally grounded in the Social Development Model [41–44], which un
derscores the importance of strong bonds between parents and children,
clear and explicit standards for healthy adolescent behavior, effective
family management practices, and reducing family conflict as key
mechanisms for reducing risk, strengthening protection, and preventing
behavioral health problems in adolescence. Program content is deliv
ered by two trained workshop leaders in weekly 2-h sessions for parents,
each with a specific focus (Table 1). Adolescents join their parents at
Session 4 to learn skills alongside their parents that can help them resist
peer and other influences to engage in risky behavior. Sessions are
interactive and skill-based, with opportunities to practice new skills and
receive feedback from workshop leaders and other attendees. Videobased vignettes demonstrate parenting skills and adolescent risk resis
tance techniques through the portrayal of a variety of illustrative family
situations. Families also receive Family Guides for each session, con
taining family activities, discussion topics, skill-building exercises, and
information on positive parenting. Weekly home practice in the form of
a family meeting is used to reinforce key concepts introduced at each
session and to strengthen family bonds.

2.5. Recruitment and baseline interview
Prior to any intervention being offered, the study team contacts all
parents, legal guardians, and/or caregivers (henceforward the term
“parents” will refer to all types of caregivers) of eligible adolescents
within participating clinics to recruit them to the study, which is called
the “Promoting Adolescent Wellness Study” (PAWS) in parent and
adolescent materials to distinguish it from the GGC intervention and
help retain blinding among parents and adolescents. After obtaining
parent consent and adolescent assent to participate and before parents in
the intervention arm receive any intervention, adolescents complete a
baseline behavioral health survey (called the PAWS Survey). Adoles
cents are resurveyed annually to assess intervention impacts on behav
ioral health outcomes in intervention arm participants compared to
control arm participants.
Additionally, in order to assess intervention uptake more broadly, all
study-eligible families receiving care from a pediatrician randomized to
the intervention arm are offered the GGC curriculum, even if they
choose not to participate in the study. However, intervention impacts
will be assessed only among adolescents for whom consent and assent
have been obtained (Fig. 1). Prior trials support a target enrollment rate
of 33% in primary care [39,40].
2.6. Intervention and control conditions

Table 1
Guiding Good Choices session objectives.

The two conditions compared in the study are the GGC intervention,
recommended by the pediatrician to parents of eligible adolescents
empaneled with an intervention arm pediatrician, and control, in which
parents of eligible adolescents empaneled with a control arm pediatri
cian experience usual pediatric primary care and are not offered GGC.
Prior to GGC initiation of enrollment calls by the study team, parents
whose adolescents are empaneled with an intervention arm pediatrician
receive a letter from their pediatric clinic or department briefly
describing and recommending the GGC program. Pediatricians also offer
an in-person recommendation to parents to enroll in GGC at eligible
adolescents' 12- or 13-year-old well visits. The study team contacts
parents within 1 week of their child's well visit or after receipt of the
letter to enroll interested parents. GGC groups are expected to include 10
to 15 parents, and each healthcare system offers 10 to 12 groups to each
cohort. Groups will be capped at approximately 20 parents to decrease
the possibility of large enrollment numbers interfering with group dy
namics and bonding. Parents in the intervention arm who opt not to
enroll in GGC groups are offered a self-guided version of GGC (see 2.6.4.
Guiding Good Choices Self-Guided Intervention).

Introduction to Guiding Good Choices
Parents meet each other, learn about the structure and promise of Guiding Good
Choices, talk about wishes for their children, and orient parents to participating in
the online environment.
Session 1. Getting Started: How to Promote Health and Well-being During the Teen
Years
Session 1 sets the context for increased risk of substance initiation and behavioral
health concerns in adolescence. Parents learn about the Social Development
Strategy, a framework for promoting adolescent well-being and preventing
behavioral problems and decide how they want to prevent problems in their own
families.
Session 2. Setting Guidelines: How to Develop Healthy Beliefs and Clear Standards
Session 2 focuses on the importance of establishing and effectively communicating
clear family rules, monitoring behavior, and providing appropriate consequences.
Parents use these skills to develop clear family guidelines and expectations for
family substance use behavior.
Session 3. Managing Conflict: How to Deal with Anger in a Positive Way
Session 3 develops skills for managing anger and reducing family conflict. Parents
learn to manage family conflict in a way that maintains and strengthens bonds with
their children.
Session 4. Avoiding Trouble: How to Say No, Keep Your Friends, and Still Have Fun
Children and parents are invited to Session 4. They learn skills children can use for
staying out of trouble and resisting peer influences while keeping their friends and
still having fun.
Session 5. Involving Everyone: How to Strengthen Family Bonds
Session 5 discusses strategies for expressing positive feelings and involving children
in developmentally appropriate family roles. Parents learn ways to strengthen
family bonds and increase children's involvement in family tasks. They also discuss
the importance of expressing love and appreciation to children.

2.6.1. Control
Control arm parents and adolescents receive care as usual and no
GGC intervention. As in the intervention arm, control arm adolescents
complete the baseline enrollment survey at the time of recruitment and
at annual follow-up times.
4
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Interventionists send participating parents short emails encouraging
attendance and containing Family Guides prior to each session. They
also offer absent parents the chance for additional contact to address
questions about missed content. Parents complete online pre-and post
test surveys to assess parents' understanding of key GGC skills and
concepts and gauge their satisfaction with interventionist skills and
delivery techniques as well as the curriculum in general.

Interventionists were also trained to provide supportive outreach to
parents enrolled in the self-guided GGC modality to motivate use of the
curriculum, assist in using the principles, tools, and skills with their
families, answer questions, and troubleshoot barriers to progress. In
terventionists also gather information about the usefulness of, satisfac
tion with, and time spent on GGC. In several bi-weekly virtual meetings,
interventionists were oriented to the three semi-scripted outreach calls
(orientation, post Session 1, and post Session 2) and their role in sending
bi-weekly emails or texts encouraging use of the self-guided in
terventions. Parents can also request additional support through the
GGC website's “Contact Us” feature, and protocols for responding to
requests within 2 business days were discussed during training
meetings.

2.6.4. Guiding good choices self-guided intervention
eGGC is a fully digital version of the GGC curriculum and is acces
sible via computer, tablet, or mobile phone. The eGGC website includes
GGC session content, exercises, and online videos, as well as regular
check-ins and coaching support from GGC interventionists intended to
enhance parent engagement with the curriculum [45,46]. Parents who
opt not to attend GGC groups are provided with a username and pass
word so they can access the eGGC website. Parents in this modality are
offered up to 12 weeks of supportive coaching by trained in
terventionists, including three supportive phone calls (an orientation to
the curriculum and check-in calls after the completion of Sessions 1 and
2). They also receive bi-weekly short email or text messages intended to
motivate use, enhance engagement, and address questions.

2.7.3. Ongoing support and technical assistance
To further support high-quality delivery of virtual group and selfguided GGC, interventionists receive ongoing support from a GGC
master trainer during the implementation phase. Meetings are oriented
towards building a supportive interventionist community of practice,
gaining further proficiency in GGC, answering questions and problemsolving issues from GGC sessions and outreach contacts, and sharing
successes and strategies for reaching parents and keeping them moti
vated to use GGC to support their families. Meetings decrease in fre
quency from weekly to monthly as interventionists gain greater
experience and fidelity with group and self-guided modalities.

2.7. Intervention orientation, training, and supervision
2.7.1. Healthcare system orientation and engagement
Throughout the study, investigative team leaders at each site meet
periodically with pediatric and adolescent medicine chiefs, clinic heads,
and pediatricians to introduce them to GGC, its rationale and evidence,
describe the study and their roles, offer pediatricians the chance to opt
out of participation, and keep them apprised of study progress. These
activities are intended to support ongoing engagement with the 5-year
study. Separately, investigative leaders meet with pediatricians
assigned to the intervention arm to orient them to their role in recom
mending GGC to parents at the adolescent well visit, offer them short
scripts that they can use in making the recommendation, and provide
them with “prescription pads” that they can give to parents which
contain a brief description of GGC and contact information for
enrollment.

2.7.4. Intervention observation
To assess both intervention implementation fidelity and parent
engagement levels beyond interventionist self-report, trained observers
attend one session for each group implemented, with the specific session
observed varying over time. Observers use the same fidelity rating sheet
used by interventionists so that two sources of data about dosage,
quality of delivery, and parent engagement can be compared (Table 3).
3. Outcome measures
Data for Reach, Effectiveness, Adoption, Implementation, and
Maintenance (RE-AIM) constructs will be collected from a variety of
sources and measures (Tables 2 and 3).

2.7.2. Interventionist training
GGC is suitable for delivery by staff with a wide range of professional
backgrounds, making implementation and dissemination in real-world
healthcare settings more feasible. While the intervention requires spe
cific GGC training, no advanced educational background is necessary to
deliver the intervention (i.e., Ph.D., M.D., master's degree). In
terventionists in this trial represent a wide range of professional back
grounds including bachelor's- and master's-level staff. Importantly,
interventionist teams in this investigation are embedded within
healthcare systems and mimic roles that exist within real-world settings
and could be used in future implementation and efforts to scale up de
livery (e.g., clinical health educator). Specific GGC intervention training
is detailed below.
Prior to COVID-19, all interventionists completed a 22-h in-person
training led by a GGC master trainer, which resulted in interventionist
certification in GGC. Training covered session content, methods for
engaging parents in each session, and issues that might arise in imple
mentation. Interventionists practiced delivering sessions and were
trained to complete fidelity rating sheets that track session adherence,
dosage, participant responsiveness, and overall quality of delivery. In
terventionists were also trained to administer anonymized GGC pre- and
post-session surveys to parents. After the COVID-19 pandemic began, a
GGC master trainer with experience delivering the curriculum held a
series of virtual weekly meetings to orient interventionists to the virtual
curriculum, provide strategies for engaging parents in the virtual envi
ronment, and offer feedback and tips to interventionists as they deliv
ered GGC virtually in mock sessions.

3.1. Effectiveness: Adolescent Behavioral health outcomes
The main objective of this investigation is to improve adolescent
behavioral health through the delivery of GGC. As was found in the prior
longitudinal trial testing GGC, the investigative team anticipates im
pacts on multiple outcomes. To reduce the number of comparisons and
control for the possibility of increased Type I error, the study team has
prioritized primary, secondary, and exploratory outcomes (Table 2). The
study's primary outcome of substance use initiation was selected
because of intervention impacts on substance use initiation established
in the prior efficacy trials. Adolescents who have already initiated sub
stance use at baseline will be excluded only from analyses examining
initiation outcomes. Importantly, recent epidemiologic data from the
National Survey on Drug Use and Health [47] suggests that the majority
of adolescents included in this investigation will not be excluded due to
prior initiation. Secondary outcomes reflect additional areas of antici
pated impact from the trial, including substance use prevalence, symp
toms of depression, and antisocial behavior incidence and prevalence.
Exploratory outcomes (e.g., anxiety symptoms, emergency department
utilization) represent additional theoretically plausible areas of inter
vention impact not previously evaluated in GGC trials.
Because many of the study's outcomes are not uniformly captured in
the EHRs of the three healthcare systems, the study team developed the
PAWS Survey to assess risk, protection, and behavioral health outcomes,
using previously validated items and scales (Table 2). After informed
consent from parents and assent from adolescents have been obtained,
5
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Table 2
Adolescent effectiveness outcomes.
Construct

a

Measurement

Primary outcome
Incidence of lifetime
substance use
initiation at study
endpoint

Table 2 (continued )
Representative items

Construct a

Measure
b

Service utilization
documented in EHR
for ICD-10 substance
use disorder
Service utilization
documented in EHR
for ICD-10
depression, anxiety,
and conduct
disorder diagnoses
Emergency
ICD-10 substance
department
use, depression,
utilization
anxiety, and conduct
disorder diagnoses
Inpatient
ICD-10 substance
hospitalization
use, depression,
utilization
anxiety, and conduct
disorder diagnoses
Proximal parent and family process outcomes
(risk and protection)
Attachment to
Total score on 2parents
item scale (0 = no,
1-yes)
Relationship
Total score on 4quality
item scale (0 = no,
1-yes)
Opportunities for
Total score on 3positive
item scale (0 = no,
involvement
1-yes)
Rewards for
Total score on 4positive
item scale (0 = no,
involvement
1-yes)

Have you ever used
marijuana (by used,
we mean smoked,
vaped, eaten, etc.)
Have you ever used an
e-cigarette or vaped
(Juul, e-hookah,
etc.)?

S2BI

Dichotomous
measure of past-year
use (yes/no) of any
of the 4 substances

How many times in
the past year (if any)
have you had
alcoholic beverages –
more than just a few
sips?
On how many days (if
any) have you used
marijuana in the past
30 days?

CASI

Have you ever stolen
something from a
store?
Have you ever
damaged or destroyed
property?
Have you ever been
arrested?
Have you ever
attacked someone
with idea of hurting
them?
In the past year, have
you ever stolen
something from a
store?

ASB

ASB

Family conflict

Over the past 2 weeks,
how often have you
been bothered by any
of the following
problems?
Feeling down,
depressed, irritable,
or hopeless

PHQ-9

Parental attitudes
favorable to
substance use

Total score on 7Over the past 2 weeks,
item scale asking
how often have you
about anxiety
been bothered by any
symptoms
of the following
experienced over the
problems?
past 2 weeks (range:
Feeling nervous,
0–3, not at all,
anxious or on edge
several days, more
Trouble relaxing
than half the days,
nearly every day)
Other substance use and mental health – dichotomized measure of
lifetime prevalence (yes/no) at study endpoint
Substance use
ICD-10 substance
disorders
use disorder
diagnoses
Psychiatric
ICD-10 depression,
disorder
anxiety, and conduct
disorder diagnoses

GAD-7

Prevalence of any
past-30-day
substance use
Lifetime incidence
of antisocial
behavior

Prevalence of any
past-year
antisocial
behavior

Dichotomous
measure of past-30day substance use
(yes/no) of any of
the four substances
Dichotomous
measure of lifetime
participation (yes/
no) in any of 7
antisocial behaviors
at the study
endpoint

Dichotomous
measure of
engagement in any
of the 7 antisocial
behaviors
Mental health symptoms at study endpoint
Depression
Total score on 9symptoms
item scale asking
about depressive
symptoms
experienced over the
past 2 weeks (range:
0–3, not at all,
several days, more
than half the days,
nearly every day)
Exploratory outcomes
Mental health
Anxiety symptoms

Representative items

Measure

Do you feel very close
to your parent(s)?

GGC/
YDS

Do you enjoy
spending time with
your parent(s)?
My parent(s) give me
lots of chances to do
fun things with them
My parent(s) notice
when I am doing a
good job and let me
know about it.
How often does your
parent know who you
are with when you are
away from home?

GGC/
YDS

We argue about the
same things in my
family over and over.

GGC/
YDS

How wrong do your
parents feel it would
be for you to…
Use marijuana?

GGC/
YDS

b

Specialty
substance use
treatment service
utilization
Specialty mental
health services
utilization

Dichotomous
measure of any
lifetime use (yes/no)
of any of 4
substances (alcohol,
marijuana, ecigarettes,
cigarettes) at any
wave

Secondary outcomes
Substance use at
study end
Prevalence of any
past-year
substance use

Measurement

CASI

Family
management

Mean score on 4item scale (range:
1–4; always, often,
sometimes, never/
almost never)
Mean score on 3item scale (range:
1–4; strongly agree,
agree, disagree,
strongly disagree)
Mean score on 4item scale (range:
1–4; very wrong,
wrong, a little bit
wrong, not wrong at
all)

GGC/
YDS
GGC/
YDS
GGC/
YDS

a
The study's primary outcome reflects GGC's emphasis on preventing
adolescent substance use. Secondary outcomes reflect impacts from GGC effi
cacy trials. Exploratory outcomes have not been previously examined but are
plausibly linked to GGC. Proximal parent and family process outcomes reflect
short-term impacts expected from exposure to GGC.
b
S2BI = Screening to Brief Intervention [87]. CASI = Comprehensive
Adolescent Severity Inventory [88]. ASB = Antisocial behavior [89]. PHQ-A =
Patient Health Questionnaire for Adolescents [90]. GAD-7 = Generalized Anx
iety Disorder 7-item scale [91]. EHR = Electronic health record. GGC/CYDS =
Scales used in GGC efficacy trials [12,92] and/or Youth Development Survey
[93].

adolescents complete the PAWS Survey online or by confidential tele
phone call with a trained study team member. The survey is adminis
tered at baseline (and a second baseline for cohort 1 due to delays from
COVID-19), with annual follow-ups at 12 and 24 months. The EHR is the
primary source of demographic data (e.g., race and ethnicity, gender,
medical insurance) and information used for evaluating impacts on
exploratory outcomes (e.g., emergency department and inpatient ser
vice utilization). Because race and ethnicity information is not always
captured in the EHR, we also ask adolescents to report this information
in the PAWS Survey.

EHR

6
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Table 3
Implementation outcomes.
Construct

Measurement

Reach
Reach
Enrollment
Attendance

Adoption
Healthcare systems
adoption
Clinic adoption
Pediatrician adoption

Implementation
Pediatrician
recommendation to
GGC
Group implementation

Sample item

Percentage of parents who are not excluded from GGC
due to impairment or because English is not their
primary language
The number and percentage of eligible families who
enrolled in the intervention
The number and percentage of families who attended
at least one GGC group session or utilized self-guided
GGC materials

EHR, PAWS study records kept by recruiters,
GGC enrollment records kept by enrollment
callers
Study enrollment records, EHR for eligible
families
GGC group attendance and self-guided
utilization records

The number and percentage of HCS approached who
agreed to implement GGC and participate in the study
The number and percentage of clinics approached
who agreed to implement GGC and participate in the
study
The number and percentage of pediatricians
approached who agreed to recommend GGC and
participate in the study

Study records

Dichotomous indicator that referral was made (yes/
no); reported by parent during enrollment calls
Number and percentage of groups held as planned

““

““

At your child's last well check visit, did your
pediatrician recommend that you enroll in
GGC?

Session implementation fidelity
Dosage
Number and percentage of sessions held as planned
Adherence
Overall quality of delivery
Parent response
Attendance
Engagement

Number and percentage of core content areas
delivered as planned
Mean score across 5 sessions (range: 1–5; very
ineffective to very effective)
Mean number of sessions attended
Mean score across 5 sessions of 2 items (range: 1–5;
not at all active to very active)

Satisfaction
Knowledge, skills,
attitudes, and behavior

Source

Mean score across 5 sessions (range: 1–5; not at all
satisfied to very satisfied)
Difference between pre- and post-session survey item
means (5-point Likert scales)

GGC enrollment records completed by
enrollment callers
Session records kept by interventionists
Session fidelity forms completed by
interventionists, and trained observers
““

How effective was your team's delivery of
this session?

How active was participation during group
discussions?
How active was participation during role
plays?
Please rate your satisfaction with the
overall session.
Good family management reduces the risk
of substance use problems
When parents get angry with their children,
they should keep the specific reasons to
themselves

““

Attendance records kept by interventionists
Session fidelity forms completed by
interventionists and trained observers
Post-session surveys completed by parents
Pre- and post-session surveys completed by
parents

EHR = Electronic health record. HCS = ….PAWS = Promoting Adolescent Wellness Study.

3.2. Implementation outcomes

and clinic staff, and to assess continued engagement, the study team will
conduct 30-min semi-structured key informant interviews with pedia
tricians and other relevant clinic staff (n = ~5 per HCS) at the beginning
of study years 4 and 5.

A second major objective of the investigation is to evaluate the
feasibility of implementing GGC routinely while providing pediatric
primary care to adolescents and their families by examining Reach,
Adoption, and Implementation outcomes (Table 3). Data is collected
from multiple sources identified in Table 3.

3.4. Costs and cost savings
3.4.1. Costs of delivering GGC
The study team will use the Ingredients Method [48,49] and an
activities-based costing approach to identify, measure, and value re
sources (e.g., personnel, materials and supplies, office space, parentincurred costs) needed to implement GGC, including capacity build
ing, intervention delivery, and ongoing support for high-quality de
livery. Staff time sheets, calendars, meeting records, and project invoices
will be used to estimate resources needed to build capacity to prepare for
implementation, deliver GGC, and provide ongoing support to involved
staff. Unit prices for each resource (e.g., staff hourly wage plus fringe
benefits rate, GGC training costs) will come from project administrative
records and the healthcare systems' administrative databases.

3.3. Maintenance
3.3.1. Maintenance of effectiveness
The study team will conduct repeated administration of the PAWS
Survey (baseline, 12- and 24-month follow-ups) to provide data for
evaluating adolescent behavioral health impacts and their maintenance
over time.
3.3.2. Maintenance of implementation
Data from implementation of GGC with parents in cohorts 1 and 2
will be used to examine maintenance of reach, adoption, and imple
mentation outcomes across cohorts. To better understand the com
plexities of sustained GGC implementation in pediatric primary care
from the perspectives of healthcare system (HCS) leaders, pediatricians,

3.4.2. Cost savings
Inflation-adjusted [50] charges obtained from healthcare systems
7
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billing records will be used to estimate costs of emergency and inpatient
service use by adolescents in the intervention and control arms and
calculate potential savings in the intervention arm.

simulation was performed in the R programming language, based on the
study's planned pediatrician and adolescent sample sizes, partially crossclassified nested design, and standardized mean difference effect sizes
(ES) ranging from 0.19 to 0.31 (approximating the 0.314–0.512 logodds effect size range found in GGC's efficacy trials [17]) at the study's
primary endpoint. The analysis was carried out on 2000 simulated co
horts of 3636 parent-adolescent dyads nested within 72 pediatricians
(64 dyads per pediatrician) using mixed-effects logistic regression
modeling [62]. Half of the pediatricians (and associated dyads) were
randomized to the intervention arm. Approximately one third of the
dyads assigned to the intervention were randomly clustered into GGClevel groups, with no more than 15 subjects per GGC intervention
group, reflecting study team assumptions about the proportion of
intervention participants choosing each GGC delivery mode. The binary
outcome for each subject was simulated according to the mixed-effects
logistic regression model, with separate random effects for pediatri
cian and GGC-level clustering. Intraclass correlation coefficients (ICCs)
for pediatricians were expected to be small (0.10 or less) because fam
ilies in each clinic are randomly assigned to pediatricians, and changing
empaneled physicians is burdensome. ICCs for GGC, which are less
consequential for study power, were also expected to be small because
GGC is a manualized intervention in which all instructors receive the
same training by a GGC master trainer. To be conservative, the simu
lations were conducted with ICCs ranging from 0.03 to 0.20.
Power analyses demonstrated that the sample size of 72 pediatricians
and 64 parent-adolescent dyads per pediatrician has adequate coverage
and at least 0.80 power to detect the lowest effect size of 0.314 (logodds) or greater at ICCPED = 0.10 and at all of the ICCGGC levels
considered. Results suggested that 72 pediatricians are more than
adequate for 0.80 power to detect hypothesized main intervention ef
fects. Sensitivity analyses in which recruitment rates were lowered to
30% also indicated 0.80 power to detect hypothesized main intervention
effects.

4. Data analyses
4.1. General analytic issues
RE-AIM analyses will use data pooled across the three healthcare
systems sites. Analysts at each healthcare system site will regularly
implement quality control procedures established in year 1 to ensure the
ongoing availability and validity of PAWS and EHR data and resolve any
issues proactively.
4.2. Analysis of behavioral health outcomes
4.2.1. General issues
4.2.1.1. Nested design. Parents and adolescents are clustered within
pediatricians at the three healthcare system sites. Analyses involving
data from parents and adolescents will use multilevel modeling to ac
count for the nested data structure and produce unbiased estimates
[51–53]. Moreover, the multilevel design and data are partially cross
classified [54]. GGC group participants are cross classified by two
random factors (pediatrician and GGC groups), as those who have the
same pediatrician may be in different GGC groups and those in the same
GGC groups may have different pediatricians. eGGC participants and
those in the control arm have nesting within one random factor
(pediatrician).
4.2.1.2. Intent-to Treat (ITT) framework. Analyses of adolescent out
comes will use an intent-to-treat (ITT) design, comparing outcomes
among adolescents in intervention and control groups as assigned by
randomization. Because pediatricians will be randomized to condition,
the effect of the intervention will be measured at the pediatrician level
by the inclusion of a dummy variable comparing the two conditions
(intervention = 1, control = 0).

4.2.2. Primary outcome analysis
Substance use initiation (one or more of alcohol, marijuana, e-ciga
rette, and tobacco use) at the study's endpoint (24-month follow-up) is
the study's primary outcome; at the 24-month follow-up assessment,
adolescents in cohorts 1 and 2 will be 14 to 15 years old on average. The
study team hypothesizes that, compared to control arm adolescents,
GGC arm adolescents will report lower rates of substance use initiation
(refer to Table 3 for the operationalization of this and other adolescent
health outcomes described here and below). Mixed-effects logistic
regression will be used for estimation of the covariate-adjusted sub
stance use initiation odds ratio (and 95% confidence interval), inter
vention vs. usual care, and associated likelihood ratio test of
significance, with the specification of random physician and GGC group
effects accounting for the partial cross classification as described above.
This regression model is a straightforward extension of that presented by
Luo et al. [54] for a partially cross-classified study design where all study
participants in one treatment arm are cross classified on two random
factors (e.g., pediatrician and GGC group) and all participants in the
other arm are nested on one random factor (e.g., pediatrician). We
extend Luo's regression model to accommodate nesting on one random
factor (pediatrician) in the eGGC subset of the intervention arm in
addition to the entire usual care arm. The model can also be used to
examine other questions of interest including, for example, symptom
counts using Poisson regression with a log link function and differences
in scale scores or means using linear regression with an identity link
function.

4.2.1.3. Covariates. All analyses will adjust for a prespecified set of
covariates and baseline measures to improve estimate precision
[53,55,56]. For adolescents, models will adjust for age, gender, race/
ethnicity, health insurance status (Medicaid vs. other), and baseline
health condition (mental health diagnoses, other significant chronic
medical conditions using Pediatric Medical Complexity Algorithm [57]).
Because the study will intervene with two cohorts of families 1 year
apart, analyses will also adjust for cohort. This variable will be inter
preted as providing evidence of generalizability across different groups
of parents as well as maintenance of implementation across 2 years. Due
to the relatively small sample of pediatricians (N = 75), models will
include a parsimonious set of pediatrician characteristics (gender, clinic,
panel size, proportion of panel insured through Medicaid) at the pedi
atrician level. The pediatrician level will also include an indicator of
clinic size, as it may be easier to fill and run GGC groups when drawing
from larger pediatrician panels with more eligible parents.
4.2.1.4. Missing data. The investigative team expects to collect data
from 85% - 90% of consented adolescents in the longitudinal follow-up.
There will be some missing data due to nonparticipation in follow-up
surveys, item nonresponse, member care received outside the system
and not captured through claims data and therefore not in the EHR, and
data lags, coding errors, and incomplete capture of relevant medical
information. To deal with potential bias, multiple imputation techniques
will be used [58–61].

4.2.3. Analyses of secondary, exploratory and family process outcomes
Analyses of the intervention arm in relation to the study's secondary,
exploratory, and family process outcomes (Table 3) will utilize gener
alized linear mixed regression, with probability distribution and link
function as appropriate to the outcome of interest (e.g., Poisson

4.2.1.5. Power. Prior to the start of the trial, a power analysis
8
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distribution and log link for symptom counts; normal distribution and
linear link for scale scores). The approach to modeling random GGC
group and pediatrician effects is as described for the primary outcome
(4.2.2.). In general terms, the investigative team hypothesizes that,
compared to adolescents in the control arm, adolescents in the GGC arm
will have more favorable behavioral health outcomes (e.g., lower levels
of antisocial behavior and violence, fewer depression or anxiety symp
toms and diagnoses, lower prevalence of past-year substance use, lower
levels of emergency department and inpatient utilization). With respect
to family process outcomes, models will be used to evaluate hypotheses
that, compared to control arm adolescents, intervention arm adolescents
will report stronger bonds with parents, clearer standards for behavior,
greater use of effective family management practices, and less favorable
attitudes towards substance use.

trained coders in accordance with broad domains of the RE-AIM model.
Differences among coders will be reconciled by consensus. Percentage
coder agreement and a Kappa Coefficient will measure interrater
agreement. Codes will be summarized within and across healthcare
systems [68] to identify themes, which will inform the feasibility of
implementing GGC and any tailoring needed across sites in the study.
4.4. Economic impact
4.4.1. Cost of implementing GGC
The study team will estimate the cost of resources required to
implement GGC, Ci, as the product of the amount of each resource used,
Qi, and its unit price (adjusted for inflationary effects on prices incurred
at different points in time), Pi. Total cost (ΣCi) and average cost per
participant (ΣCi/n) across all healthcare system sites and within site will
be estimated. The costs of key activities, such as capacity building, and
costs borne by different stakeholders (healthcare system, clinic, parent)
will be estimated by summing costs of resources relevant to each activity
or stakeholder. The marginal cost of serving one more parent will be
estimated by summing the costs of resources that vary on the margin (e.
g., parent materials, engagement staff time, enrollment outreach).

4.2.4. Generalizability
To assess hypotheses that GGC impacts on adolescent health gener
alize across study cohort, adolescent gender and race/ethnicity, and
healthcare system, the study team will conduct exploratory moderation
analyses. Moderation will be evaluated by including a cross-level
interaction term in analysis models (i.e., intervention at level 2 by in
dividual characteristic at level 1) and testing the interaction term for
statistical significance. Because power to detect cross-level interactions
may be limited [63–66], the study team will also conduct exploratory
subgroup analyses to provide additional information about the strength
and direction of relationships that will aid in the interpretation of
moderation.

4.4.2. Cost-effectiveness analysis
Cost-effectiveness analysis (CEA) will be used to evaluate the hy
pothesis that GGC is cost effective. Short-term cost-to-value will be
indicated by the incremental cost-effectiveness ratio (ICER), which ex
presses the additional cost per unit of outcome (e.g., the cost per one
fewer case of marijuana initiation or cost per one fewer case of
depression in GGC relative to control). The primary outcome for the CEA
will be substance use initiation at the study endpoint. Two sets of ICERs
will be calculated to reflect costs from the healthcare system perspective
and comprehensive costs [49]. To determine whether GGC is cost
effective, ICERs will be compared to a range of values indicating will
ingness to pay (WTP) per unit of outcome (e.g., willingness to pay to
reduce one case of depression).
If evidence for GGC impacts on emergency department and/or
inpatient service utilization is found, the study team will also estimate
short-term cost savings to the healthcare system experienced over the
life of the project. Total cost savings for each service utilization domain
will be calculated as the difference between inflation-adjusted [69]
charges to adolescents in the intervention and control arms obtained
from billing records. Differences across both domains will be summed to
estimate total savings. Average cost savings (by domain and total) per
participant will also be calculated as the difference in utilization cost per
intervention arm adolescent less utilization cost per control arm
adolescent. Cost savings can be compared to the cost of implementing
GGC to ascertain the degree to which implementation costs are offset
through savings in the short term.

4.3. Implementation outcomes analysis
4.3.1. General approach to implementation analyses
Implementation analyses focus on pragmatic questions about reach,
adoption, and implementation of GGC that are of interest to healthcare
systems. These analyses will generally be descriptive and focused on
point and interval estimation of key constructs in the aggregate and, to
assess generalizability, by healthcare system, clinic, and cohort
(Table 3). Differences will be evaluated at a type 1 error rate of 0.05
using appropriate statistical tests (e.g., t-tests to evaluate differences in
means, chi square to evaluate differences in proportions).
4.3.2. Parent response to GGC
Parent response to GGC will be evaluated in terms of session atten
dance, parent engagement, satisfaction, and gains in knowledge, atti
tudes, and skills that promote healthy parenting and positive youth
development. Mean levels of attendance, engagement, and satisfaction
will be reported as described as above. To evaluate hypothesized im
provements in parents' knowledge and parenting skills, attitudes, and
behavior after completing GGC, the study team will compare parent preand posttest scale scores (e.g., clear standards for adolescent behavior,
proactive communication). The team will utilize the same multilevel
modelling approach described previously (see 4.2.2. Primary Outcome
Analysis and 4.2.3. Analyses of Secondary, Exploratory, and Family Process
Outcomes), with posttest score as the dependent variable, adjusting for
pretest score and participant-level (e.g., participant gender, educational
attainment) and group-level (e.g., group, healthcare system) covariates.

4.4.3. Benefit-cost analysis
Benefit-cost analysis conducted from a societal perspective will be
used to evaluate the hypothesis that GGC's long-term economic benefit
will exceed comprehensive implementation costs. GGC's effects on
adolescent outcomes will be monetized using models developed by the
Washington State Institute for Public Policy [70] and previously applied
to prevention benefit-cost studies [71,72]. Benefits will be projected
over the lifetime of adolescents by linking intervention-attributable re
ductions in health-risk behaviors (e.g., drug use, depression, de
linquency/crime) to benefits expected to accrue over participants'
lifetimes (e.g., lower healthcare costs, increased earnings). GGC's net
present value (NPV) will be estimated as the difference between dis
counted, inflation-adjusted benefits and costs on a per-participant basis.
NPV greater than zero will indicate that GGC is cost beneficial. To ac
count for sources of error in estimates, Monte Carlo methods will be used
to estimate GGC's NPV under a range of assumptions.

4.3.3. Maintenance of healthcare system engagement in GGC
To better understand the complexities of sustained GGC imple
mentation in pediatric primary care from the perspectives of healthcare
system leaders and pediatricians/clinic staff, the study team will use a
qualitative, inductive approach to analyzing detailed notes from stake
holder meetings and interviews with pediatricians. Meeting notes will be
reviewed for completeness. Interview audiotapes will be transcribed.
They will be analyzed using NVivo, Atlas.ti, or a similar software
application that facilitates the organization and analysis of unstruc
tured, qualitative data [67]. Data will be independently coded twice by
9
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4.5. Continuous quality improvement

suggest strong potential for scaling evidence-based parent-focused pre
vention programs in pediatric primary care, and ultimately improving
adolescent health trajectories. Although several reviews suggest
prevention-focused parenting programs can be effective when offered in
pediatric primary care [82–84], scaling effective parenting programs
within pediatric primary care necessitates implementation protocols
that fit within routine practice and varied organizational structures; are
feasible to deliver; and appeal to diverse populations, including those
who are marginalized, economically disadvantaged, and underrepre
sented [79]. With its emphasis on assessing feasibility and effectiveness
of implementing GGC in 10 clinics located in three regional healthcare
systems with distinct member profiles, the GGC4H trial is expected to
generate new knowledge bearing on implementation at scale. The lowburden implementation strategy, in which pediatricians recommend
GGC to parents but interventionists carry out the intervention, holds
promise as a sustainable implementation approach that overcomes
barriers of pediatrician time constraints, low provider self-efficacy in
addressing behavioral health concerns, and perceptions about disci
plinary scope and expertise [85,86].
The current investigation has a number of other advantages, which
include assessing GGC effectiveness among a racially, ethnically, and
socioeconomically diverse sample, and evaluating previously unexam
ined reductions in emergency department and inpatient service uti
lization—critical and costly outcomes particularly salient to health
system leaders and policymakers—as well as broader adolescent health
outcomes. It is also being conducted within the NIH Healthcare Systems
Research Collaboratory, which provides the opportunity to examine
study findings within the context of other pragmatic trials, to collaborate
with other scientists engaged in pragmatic trials in healthcare systems,
and to receive support from the Collaboratory's extensive network of
methodological and topical (e.g., EHR data, patient-reported outcomes,
ethics) experts.

To ensure continuous quality improvement, the study team regularly
(monthly, semi-annually, or annually depending on the construct and
measure) reviews data sources to identify (a) consistency with, adap
tations to, departures from established engagement, enrollment, and
implementation protocols; (b) possible barriers to engagement, concerns
about workflow issues, and the like; and (c) possible low rates of GGC
group enrollment and attendance, and self-study engagement/utiliza
tion. When concerns are identified, project investigators follow up with
relevant staff to better understand the concern and respond appropri
ately (e.g., additional support to interventionists) or refine the approach
where needed (e.g., tailoring protocols to better fit clinic workflow).
At the end of each implementation year, the study team will table
descriptive statistics for RE-AIM constructs by healthcare system and
clinic and, where relevant, by pediatrician and parent characteristics (e.
g., enrollment rates, attendance by parent gender, ethnicity). The team
will review all results and use them as the basis for recommendations for
improving and refining the approach to implementing GGC. Some rec
ommendations may apply to all healthcare systems while others may
apply to a particular clinic or healthcare system.
5. Discussion
The current investigation is an innovative test of the feasibility and
effectiveness of implementing GGC, a universal, evidence-based pro
gram that provides developmentally relevant anticipatory guidance to
parents of young adolescents in three geographically diverse, large in
tegrated healthcare systems. Prior studies have shown that evidencebased parenting interventions can achieve sustained reductions in
health-risk behaviors and behavioral health concerns [73,74], but their
public health impact has been limited by low rates of uptake when
offered in community and agency settings [40]. Posited reasons for low
uptake include stigma and concerns about being viewed as a “bad”
parent, the appropriateness of the sponsoring organization to address
parenting and parent education, and stable funding to provide reim
bursement for services [39].
Pediatric primary care offers an opportune setting for implementing
and scaling parent-focused prevention programs to better support par
ents and improve adolescent health and wellbeing. Pediatric primary
care settings serve as patient-centered medical homes for children and
adolescents where multidisciplinary care teams provide quality holistic
care. These settings reach large numbers of demographically and
economically diverse children and families and continue to expand their
capacity to address and treat behavioral health issues [75,76]. Expan
sion of the Children's Health Insurance Program and passage of the
Affordable Care Act has increased the availability of health insurance for
children and thereby expanded access to pediatric preventive care [77].
Recent studies indicate that the proportion of children under age 18
without health insurance declined to 4.7% in 2020 [78], 96.4% had a
pediatric medical home [39], and three quarters of those under age 18
accessed pediatric care within the past 6 months, nearly always
accompanied by a parent [79]. Supporting parents in pediatric primary
care is also increasingly becoming a clinical practice norm [80]. The
American Academy of Pediatrics' Bright Futures guidelines recognize,
for example, the critical role parents play in the process of preventing
adolescent behavioral health problems, and recommend that providers
offer developmentally tailored anticipatory guidance and education to
all parents [24]. Several state Medicaid agencies allow for maternal
depression screenings performed in pediatric care to be billed for and
covered [81]. Parents have also expressed generally favorable attitudes
towards prevention services offered in primary care, particularly in
relation to mental health and substance use behavior [75].
Growth in integrated behavioral and primary healthcare, pediatric
primary care reach among children and families, norms for supporting
parents, and favorable parent attitudes towards preventive services all

5.1. COVID-19: An unexpected challenge
The novel coronavirus pandemic that began in early 2020 necessi
tated rapid modifications and adaptations to healthcare delivery. Tele
health service delivery has become a new standard of care in many
healthcare settings, and clinical research studies like GGC4H were
required to adapt to this new standard. Virtual adaptation of the inter
vention required swift work to ensure that intervention delivery
retained all core curricular components and fostered meaningful
engagement and parent relationships through a virtual modality.
Although the adaptation process was unanticipated, the virtual modality
provides unique benefits, including addressing potential barriers to
participation, such as transportation costs and childcare needs. Tech
nological barriers to participation (e.g., families lack a computer or
internet service) will be at least partially mitigated by mobile phone
access to virtual groups. The virtual modality may reduce intervention
delivery cost, increase efficiency, and retain or even increase its appeal
to healthcare systems leaders as it remains consistent with the current
healthcare delivery approach. The virtual modality may become even
more germane as health systems shift services, including many pre
ventive psychoeducational programs, to virtual modalities in the wake
of the COVID-19 pandemic.
5.2. Limitations
While this investigation is expected to yield important novel infor
mation about the feasibility and effectiveness of offering universal
anticipatory guidance and education to parents of early adolescents in
primary care settings, there are limitations. The study focuses on
assessing generalizability across the three participating healthcare sys
tems, but two of the three will implement GGC in multiple clinics; and
variation in findings across clinics will not be fully explored due to
budget and statistical (power) reasons. Moreover, because of the need to
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demonstrate effectiveness before each healthcare system can broadly
embrace a new service, the investigation will be implemented in a
limited number of clinics within each large healthcare system. Due to
budget constraints, the study is collecting limited data from parents,
choosing to prioritize reports from adolescents. Additionally, the study
team personally contacts all parents for recruitment and enrollment.
This outreach method is not pragmatic and future implementation
studies could adopt a more pragmatic approach to enrollment. Finally,
though not a limitation per se, within the context of a pragmatic trial,
the Adolescent Behavioral Health
(PAWS) Survey is not a pragmatic source of data relative to the EHR,
requiring staff time to administer and incentives to thank adolescents for
their participation. However, a survey was deemed necessary because
EHRs of participating sites do not consistently capture data about this
study's primary and secondary adolescent behavioral health outcomes.
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5.3. Conclusion
The investigative team expects that implementation of Guiding Good
Choices within primary care clinics will fill an unmet need for effective
prevention programs for parents within pediatric primary care settings,
increasing the program's reach and public health impact. Although the
novel coronavirus pandemic has shifted the way GGC groups are offered
to parents from in-person to virtual, the study design has remained
intact, with potential to offer important new knowledge about parent
response to and effectiveness of an intervention offered virtually within
the course of routine pediatric primary care.
Supplementary data to this article can be found online at https://doi.
org/10.1016/j.cct.2021.106621.
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